中國醫療網絡(00383.HK)供股獲超額認購
中國醫療網絡(00383.HK)公布,有關建議2供1基準進行供股之結果,已接獲合共26份有效申請及接納,供股獲超額認購3,826.34萬股供股股份,佔根據供股可供認購之供股股份總數約10.57%。供股所得款項淨額約為3.09億元,擬用於為發展昆明醫院二期提供資金。
公司指出,合共1.81億股額外供股股份已根據額外申請表格申請。由於額外申請,可能觸發天安(00028.HK)的無條件強制性要約。中國醫療網絡股份自6月9日起停牌,並將繼續暫停買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.